The effect of glatiramer acetate treatment on pre- existing headaches in patients with MS

During the first 6 months of glatiramer acetate therapy in 82 consecutive patients with multiple sclerosis, in only 6% frequency of pre-existing headaches increased by more than 50%. This is less than the headache aggravation reported in an earlier study in up to 35% of patients during the first 6 m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2006-01, Vol.66 (2), p.275-277
Hauptverfasser:	PÖLLMANN, Walter, ERASMUS, Lutz-Peter, FENEBERG, Wolfgang, STRAUBE, Andreas
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - therapeutic use Adult Biological and medical sciences Female Glatiramer Acetate Headache - epidemiology Headache - etiology Humans Immunomodulators Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Incidence Interferon-beta - therapeutic use Male Medical sciences Middle Aged Multiple Sclerosis - complications Multiple Sclerosis - drug therapy Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Peptides - adverse effects Peptides - therapeutic use Pharmacology. Drug treatments Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	During the first 6 months of glatiramer acetate therapy in 82 consecutive patients with multiple sclerosis, in only 6% frequency of pre-existing headaches increased by more than 50%. This is less than the headache aggravation reported in an earlier study in up to 35% of patients during the first 6 months on interferon beta.
ISSN:	0028-3878 1526-632X
DOI:	10.1212/01.wnl.0000194317.75449.91